Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Rob S Sellar & Karl S Peggs. (2014) Therapeutic strategies for cytomegalovirus infection in haematopoietic transplant recipients: a focused update. Expert Opinion on Biological Therapy 14:8, pages 1121-1126.
Read now
Read now
Articles from other publishers (21)
M. P. Paramonova, E. S. Gureeva, A. A. Ozerov, R. Snoeck, G. Andrei, D. A. Aleksandrov, A. L. Khandazhinskaya, M. S. Novikov & S. N. Kochetkov. (2023) Synthesis of 1-[ω-(Bromophenoxy)alkyl]-3-naphthalenylmethyl Derivatives of Uracil and Their Analogues As Probable Inhibitors of Human Cytomegalovirus Replication. Doklady Biochemistry and Biophysics 509:1, pages 41-46.
Crossref
Crossref
M. P. Paramonova, E. S. Gureeva, A. A. Ozerov, R. Snoeck, G. Andrei, D. A. Alexandrov, A. L. Handazinskaya, M. S. Novikov & S. N. Kochetkov. (2023) Synthesis of 1-[ω-(Bromophenoxy)alkyl]-3-Naphthalenylmethyl Uracil Derivatives and Their Analogues as Probable Inhibitors of Human Cytomegalovirus Replication. Doklady Biochemistry and Biophysics 507:1, pages 357-362.
Crossref
Crossref
Jing Zhang, Jinpeng Cao, Runhui Zheng, Mengqiu Yu, Zhengfang Lin, Caixia Wang, James McCluskey, Ji Yang, Zhenjun Chen, Alexandra J. Corbett, Pengxing Cao, Wenjian Mo & Zhongfang Wang. (2022) The establishment of a cytomegalovirus -specific CD8+ T-cell threshold by kinetic modeling for the prediction of post-hemopoietic stem cell transplant reactivation. iScience 25:11, pages 105340.
Crossref
Crossref
Phaedon Zavras, Yiqi Su, Jiaqi Fang, Anat Stern, Nitasha Gupta, Yuexin Tang, Amit Raval, Sergio Giralt, Miguel Angel Perales, Ann A. Jakubowski & Genovefa A. Papanicolaou. (2020) Impact of Preemptive Therapy for Cytomegalovirus on Toxicities after Allogeneic Hematopoietic Cell Transplantation in Clinical Practice: A Retrospective Single-Center Cohort Study. Biology of Blood and Marrow Transplantation 26:8, pages 1482-1491.
Crossref
Crossref
Z. Hakimi, S. Ferchichi, S. Aballea, I. Odeyemi, M. Toumi, M. English & I. Yakoub-Agha. (2018) Burden of cytomegalovirus disease in allogeneic hematopoietic cell transplant recipients: a national, matched cohort study in an inpatient setting. Current Research in Translational Medicine 66:4, pages 95-101.
Crossref
Crossref
Chien-Ting Lin, Po-Ren Hsueh, Shang-Ju Wu, Ming Yao, Bor-Sheng Ko, Chi-Cheng Li, Cheng-An Hsu, Jih-Luh Tang & Hwei-Fang Tien. (2018) Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial. Biology of Blood and Marrow Transplantation 24:11, pages 2310-2315.
Crossref
Crossref
Ondřej Pelák, Jan Stuchlý, Ladislav Król, Petr Hubáček, Petra Keslová, Petr Sedláček, Renata Formánková, Jan Starý, Ondřej Hrušák & Tomáš Kalina. (2017) Appearance of cytomegalovirus-specific T-cells predicts fast resolution of viremia post hematopoietic stem cell transplantation. Cytometry Part B: Clinical Cytometry 92:5, pages 380-388.
Crossref
Crossref
Andy Roemhild & Petra Reinke. (2016) Virus-specific T-cell therapy in solid organ transplantation. Transplant International 29:5, pages 515-526.
Crossref
Crossref
Denis A. Babkov, Anastasia L. Khandazhinskaya, Alexander O. Chizhov, Graciela Andrei, Robert Snoeck, Katherine L. Seley-Radtke & Mikhail S. Novikov. (2015) Toward the discovery of dual HCMV–VZV inhibitors: Synthesis, structure activity relationship analysis, and cytotoxicity studies of long chained 2-uracil-3-yl-N-(4-phenoxyphenyl)acetamides. Bioorganic & Medicinal Chemistry 23:21, pages 7035-7044.
Crossref
Crossref
C. Stuehler, G. Stüssi, J. Halter, J. Nowakowska, A. Schibli, M. Battegay, J. Dirks, J. Passweg, D. Heim, A. Rovo, C. Kalberer, C. Bucher, M. Weisser, A. Dumoulin, H.H. Hirsch & N. Khanna. (2015) Combination therapy for multidrug-resistant cytomegalovirus disease. Transplant Infectious Disease 17:5, pages 751-755.
Crossref
Crossref
Simone Thomas, Sebastian Klobuch, Jürgen Podlech, Bodo Plachter, Petra Hoffmann, Angelique Renzaho, Matthias Theobald, Matthias J. Reddehase, Wolfgang Herr & Niels A. W. Lemmermann. (2015) Evaluating Human T-Cell Therapy of Cytomegalovirus Organ Disease in HLA-Transgenic Mice. PLOS Pathogens 11:7, pages e1005049.
Crossref
Crossref
Edith Acquaye-Seedah, Zachary P. Frye & Jennifer A. Maynard. 2015. Antibodies for Infectious Diseases. Antibodies for Infectious Diseases
273
288
.
Michael Boeckh, William J. Murphy & Karl S. Peggs. (2015) Reprint of: Recent Advances in Cytomegalovirus: An Update on Pharmacologic and Cellular Therapies. Biology of Blood and Marrow Transplantation 21:2, pages S19-S24.
Crossref
Crossref
Michael Boeckh, William J. Murphy & Karl S. Peggs. (2015) Recent Advances in Cytomegalovirus: An Update on Pharmacologic and Cellular Therapies. Biology of Blood and Marrow Transplantation 21:1, pages 24-29.
Crossref
Crossref
Lorea Beloki, Natalia Ramírez, Eduardo Olavarría, Edward R. Samuel & Mark W. Lowdell. (2014) Manufacturing of highly functional and specific T cells for adoptive immunotherapy against virus from granulocyte colony-stimulating factor–mobilized donors. Cytotherapy 16:10, pages 1390-1408.
Crossref
Crossref
Peter Braendstrup, Bo Kok Mortensen, Sune Justesen, Thomas Østerby, Michael Rasmussen, Andreas Martin Hansen, Claus Bohn Christiansen, Morten Bagge Hansen, Morten Nielsen, Lars Vindeløv, Søren Buus & Anette Stryhn. (2014) Identification and HLA-Tetramer-Validation of Human CD4+ and CD8+ T Cell Responses against HCMV Proteins IE1 and IE2. PLoS ONE 9:4, pages e94892.
Crossref
Crossref
Edith A. Seedah, Zachary P. Frye & Jennifer A. Maynard. (2014) Immunotherapeutic Approaches To Prevent Cytomegalovirus-Mediated Disease. Microbiology Spectrum 2:1.
Crossref
Crossref
Shin-ichiro Fujiwara, Kazuo Muroi, Raine Tatara, Ken Ohmine, Tomohiro Matsuyama, Masaki Mori, Tadashi Nagai & Keiya Ozawa. (2014) Intrathecal Administration of High-Titer Cytomegalovirus Immunoglobulin for Cytomegalovirus Meningitis. Case Reports in Hematology 2014, pages 1-3.
Crossref
Crossref
H J Stauss & E C Morris. (2013) Immunotherapy with gene-modified T cells: limiting side effects provides new challenges. Gene Therapy 20:11, pages 1029-1032.
Crossref
Crossref
Sanja Mandaric Jeitziner, Senta M. Walton, Nicole Torti & Annette Oxenius. (2013)
Adoptive transfer of cytomegalovirus-specific effector CD4
+
T cells provides antiviral protection from murine CMV infection
. European Journal of Immunology 43:11, pages 2886-2895.
Crossref
Crossref
Jing Zhang, Jinpeng Cao, Runhui Zheng, Mengqiu Yu, Zhengfang Lin, Caixia Wang, James McCluskey, Ji Yang, Zhenjun Chen, Alexandra J. Corbett, Pengxing Cao, Wenjian Mo & Zhongfang Wang. (2022) The Establishment of a CMV-Specific CD8 <sup>+</sup> T-Cell Threshold by Kinetic Modelling for Prediction of Post-HSCT Reactivation. SSRN Electronic Journal.
Crossref
Crossref